Latest Biofortuna news

Biofortuna supports World Cancer Day

We are proud to support the UICC's World Cancer Day initiative ...

Biofortuna shortlisted for 2020 Bionow awards.

We are delighted to share the news that we have been shortlisted for the 2020 BioNow awards. ...

Biofortuna sets a new production record.

Biofortuna sees record production levels across November and December ...

Biofortuna appointed as CMO for QuantuMDx CE–marked assay

Biofortuna has provided assay development and manufacturing support to QuantuMDx Group Limited to assist in the manufacturing scale-up, regulatory ...

Coronavirus Update from Biofortuna

In light of the current situation with COVID-19, we would like to take this opportunity to assure you that plans have been put into place to ensure ...

Biofortuna unveils ampDRY™ air-dried master mix

Biofortuna (Liverpool, UK) – the international IVD contract research and contract manufacturing company – will be launching ampDRY™, its patent ...

Previous news & articles

Biofortuna closes £1.6M funding round

Biofortuna Ltd, a UK-based diagnostics company offering molecular diagnostic products and contract manufacturing services, has raised £1.6M in its ...

Biofortuna expands its immunoassay development and manufacturing services

Biofortuna is expanding its IVD service portfolio to provide a greater focus on immunoassay design, development and manufacture. The company has made ...

Biofortuna FDA Inspection Completed Successfully

Biofortuna have successfully completed an FDA site inspection to retain their FDA registered manufacturing site status. The inspection was carried ...

Record year for Biofortuna Contract Services division

Biofortuna Ltd is pleased to announce a record year of growth for its IVD Contract Services division. This growth has been driven by the expansion of ...

Biofortuna invests in climate control facilities

Biofortuna Ltd, a diagnostics company based in Wirral UK, announces significant investment into its IVD Contract Manufacturing Division in order to ...

Biofortuna launches its new approach to custom IVD manufacture and development services

Diagnostics company Biofortuna will mark the 2015 AACC Annual Meeting and Clinical Lab Expo in Atlanta, USA, with the launch of a broader portfolio ...

Biofortuna Ltd appoints new Chairman to lead next phase of growth

UK based molecular diagnostics company Biofortuna has appointed a new Chairman to lead the next phase of growth. Life sciences expert Ian Johnson ...

Biofortuna Ltd closes a £1.5m funding round

Biofortuna Ltd, the UK based molecular diagnostics company specialising in its proprietary freeze-dried diagnostics and contract services, announces ...

Upcoming events

As all major exhibitions and events have been postponed due to the Covid-19 pandemic, we have no current plans to exhibit in the near future.

However, we can still meet virtually!  Fill in the form below to arrange a Zoom or Microsoft teams meeting (or a good old fashioned telephone call), to discuss how we can help you take your diagnostic assays from development to commercialisation.

Do you have a project that we can help with? Contact us now to arrange a meeting...
I understand that Biofortuna will contact me and I will receive subsequent email updates (see Website Privacy Policy).